Joshua Robak, MD

Dr Robak is a second-year psychiatry resident at Creighton University School of Medicine in Omaha, Nebraska.

Articles

Antipsychotics and the QTc Interval During Delirium in the Intensive Care Unit: A Secondary Analysis of a Randomized Clinical Trial

Joshua Robak, MD;Nishi Modi, MBBS;Haley Schuster, MD;Mark Mullen, MD;Rajesh R. Tampi, MD, MS, DFAPA, DFAAGP

May 9th 2025

Research reveals that IV haloperidol and ziprasidone are safe for treating delirium in patients that are critically ill, showing minimal impact on QTc intervals.

Zuranolone for the Treatment of Adults With Major Depressive Disorder

Joshua Robak, MD;Lior Hilsenrath, MD;Abigail Jaeger, MD;Mark Mullen, MD;Rajesh R. Tampi, MD, MS, DFAPA, DFAAGP

July 12th 2024

This randomized, placebo-controlled, phase 3 clinical trial showed that a 14-day treatment course of oral zuranolone 50 mg/day in MDD led to significantly greater improvements in depressive symptoms when compared with placebo.

A medical student at the University of North Dakota and member of the Climate Psychiatry Alliance writes about the effects of climate change on mental health.

Climate Distress in the Peace Garden State

Joshua Robak, MD

February 11th 2022

A fourth-year medical student at the University of North Dakota and member of the Climate Psychiatry Alliance writes about his concerns regarding climate effects on health.